Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.

Rothman RL, Stewart TG, Mourad A, Boulware DR, McCarthy MW, Thicklin F, Garcia Del Sol IT, Garcia JL, Bramante CT, Shah NS, Singh U, Williamson JC, Rebolledo PA, Jagannathan P, Schwasinger-Schmidt T, Ginde AA, Castro M, Jayaweera D, Sulkowski M, Gentile N, McTigue K, Felker GM, DeLong A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Hanna GJ, Shenkman E, Hernandez AF, Naggie S, Lindsell CJ, Accelerating COVID-19 Therapeutic Interventions and Vaccines–6 Study Group and Investigators

Open source

DOI: 10.1001/jamanetworkopen.2024.39332
Published: 2024 Oct 1
Container: JAMA network open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2024.39332,
  title = {Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.},
  author = {Rothman RL and Stewart TG and Mourad A and Boulware DR and McCarthy MW and Thicklin F and Garcia Del Sol IT and Garcia JL and Bramante CT and Shah NS and Singh U and Williamson JC and Rebolledo PA and Jagannathan P and Schwasinger-Schmidt T and Ginde AA and Castro M and Jayaweera D and Sulkowski M and Gentile N and McTigue K and Felker GM and DeLong A and Wilder R and Collins S and Dunsmore SE and Adam SJ and Hanna GJ and Shenkman E and Hernandez AF and Naggie S and Lindsell CJ and Accelerating COVID-19 Therapeutic Interventions and Vaccines–6 Study Group and Investigators},
  year = {2024},
  journal = {JAMA network open},
  doi = {10.1001/jamanetworkopen.2024.39332},
  url = {https://doi.org/10.1001/jamanetworkopen.2024.39332}
}

RIS

TY  - JOUR
TI  - Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
AU  - Rothman RL
AU  - Stewart TG
AU  - Mourad A
AU  - Boulware DR
AU  - McCarthy MW
AU  - Thicklin F
AU  - Garcia Del Sol IT
AU  - Garcia JL
AU  - Bramante CT
AU  - Shah NS
AU  - Singh U
AU  - Williamson JC
AU  - Rebolledo PA
AU  - Jagannathan P
AU  - Schwasinger-Schmidt T
AU  - Ginde AA
AU  - Castro M
AU  - Jayaweera D
AU  - Sulkowski M
AU  - Gentile N
AU  - McTigue K
AU  - Felker GM
AU  - DeLong A
AU  - Wilder R
AU  - Collins S
AU  - Dunsmore SE
AU  - Adam SJ
AU  - Hanna GJ
AU  - Shenkman E
AU  - Hernandez AF
AU  - Naggie S
AU  - Lindsell CJ
AU  - Accelerating COVID-19 Therapeutic Interventions and Vaccines–6 Study Group and Investigators
PY  - 2024
JO  - JAMA network open
DO  - 10.1001/jamanetworkopen.2024.39332
UR  - https://doi.org/10.1001/jamanetworkopen.2024.39332
ER  -

APA

RL, R., TG, S., A, M., DR, B., MW, M., F, T., IT, G. D. S., JL, G., CT, B., NS, S., U, S., JC, W., PA, R., P, J., T, S., AA, G., M, C., D, J., M, S., N, G., K, M., GM, F., A, D., R, W., S, C., SE, D., SJ, A., GJ, H., E, S., AF, H., S, N., CJ, L., & Investigators, A. C. T. I. A. V. S. G. A. (2024). Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2024.39332

Source records

pubmed · retrieved 2026-09-26T04:14:58.625Z